Nang Kuang Partners with Orion to Commercialize Patented Inhalation Products in Mainland China Market
In December 2022, Nang Kuang has entered into a long-term exclusive licensing partnership with Orion Corporation(Orion)for the commercialization of Budesonide Inhalation Powder and Salbutamol Sulfate Inhalation Powder. Orion is a globally operating Finnish pharmaceutical company founded in 1917. Orion develops, manufactures and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company is a … Continue reading